Originally Posted by
blobbles
Sure, sales of CertNDx went from $1 million in their first year (which looks like this will not be achieved by PEB who have a better test, mind) to $14 million two years later with CMS coverage (until it was removed around 2013).
That's not bad but if PEB follow a similar path, we can expect $14 million of sales in 2 years with CMS coverage. Not sure about you, but I don't think that sort of possible sales in 2 years supports the almost $300 million market cap we currently have, in my book. I shudder to think of any applicable ratio currently to value the company.
I think people need to switch from "This has HUGE potential" mindset to cold hard facts of sales numbers, profit/loss margins etc when they assess this company now. While they may be only in their first year, they appear to have a fairly revolutionary product that they can't sell. That's less than good in my books and smells a bit funny. They seem to have the right people set up in the states, the right product, gaining the right accreditations and deals, but can't sell. Why? What is the block? If they are honest about it, they should tell us what this is.